Raymond James Financial
RCEL icon

Raymond James Financial’s Avita Medical RCEL Stock Holding History

Raymond James Financial’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,528
Closed -$8.08K – 6357
2025
Q2 		$8.08K Buy
+1,528
New +$11.1K ﹤0.01% 6008

Other funds holding RCEL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Raymond James Financial's RCEL Position: Q3 2025 in Review

Raymond James Financial sold out of Avita Medical (RCEL) in Q3 2025, closing a stake of 1,528 shares — an estimated $8.08K sold.

Raymond James Financial first reported a position in RCEL in Q2 2025 and held it in 1 quarter. The position peaked at $8.08K in Q2 2025. 76 funds tracked by Wall St. Rank hold RCEL as of Q3 2025.

  • Raymond James Financial reported no remaining Avita Medical position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 1,528 Avita Medical shares in Q3 2025, an estimated $8.08K.
  • Raymond James Financial first reported a position in Avita Medical in Q2 2025 and held it in 1 quarter.
  • Raymond James Financial's Avita Medical position peaked at $8.08K in Q2 2025.
  • 76 funds tracked by Wall St. Rank held Avita Medical as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.